查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2038978

數位生物標記市場：按類型、資料類型、技術平台、最終用戶和地區分類

Digital Biomarker Market, By Type, By Data Type, By Technology Platform, By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球數位生物標記市場預計在 2026 年達到 48.5 億美元，預計到 2033 年將達到 169 億美元。 2026 年至 2033 年的年複合成長率（CAGR）預計為 19.5%。

報告範圍 報告詳情
基準年： 2025 2026年市場規模： 48.5億美元
歷史數據時期： 2020-2024 預測期： 2026-2033
2026年至2033年預測期間的複合年成長率： 19.50% 2033年市場規模預測： 169億美元

數位生物標記被認為是現代醫療保健領域的一項突破性進展，因為它提供了利用穿戴式裝置、智慧型手機和其他感測器等各種數位技術對生物數據進行定量分析的機會。與需要頻繁就醫和檢測的傳統生物標記不同，數位生物標記可以持續、被動地收集信息，從而能夠更準確地評估患者的健康狀況、各種疾病的進展以及治療效果。數位生物標記的演進正在推動當前醫療保健模式轉向數據驅動、結果導向模式。

全球數位生物標記產業涵蓋心血管、神經、呼吸和精神疾病治療等領域的廣泛應用。數位生物標記可從多種資料來源生成，包括生理資訊、行為資料、環境指標和其他資訊。感測器、雲端運算和數據聚合技術的進步正在推動數位生物標記的發展和廣泛應用。

市場動態

全球數位生物標記市場的發展主要得益於醫療營運數位化、以價值為導向的醫療服務模式以及相關研究的推進。更具體地說，醫療領域的相關人員正在尋求收集關於患者的頻繁且客觀的數據，以提升決策能力並改善患者治療效果。透過利用數位生物標記，患者可以收集數據並將其作為可量化的數位終點應用於臨床實踐和藥物研究。此外，雲端運算系統、行動醫療技術以及不斷提升的資料互通性也增強了上述解決方案的可擴展性和適用性。

然而，數位生物標記在醫療保健領域的應用面臨許多限制，例如無法控制不同設備間的數據差異、檢驗方案驗證不足以及數據管治的挑戰。儘管如此，數位雙胞胎技術、多模態資料分析以及醫療保健、製藥和技術等各領域相關人員之間的合作仍蘊藏著許多機會。數位生物標記的應用範圍從研究擴展到人群健康管理、風險識別和治療，預計將進一步推動數位生物標記市場的成長。

本研究的關鍵特徵

  • 本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
  • 此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
  • 本研究根據以下參數創建了全球數位生物標記市場主要公司的概況：公司亮點、產品系列、關鍵亮點、財務表現和策略。
  • 透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
  • 全球數位生物標記市場報告的目標受群眾外包括該行業的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以透過分析全球數位生物標記市場中使用的各種策略矩陣輕鬆做出決策。

目錄

第1章：研究目標與前提條件

  • 研究目標
  • 前提
  • 簡稱

第2章 市場範圍

  • 報告摘要
    • 市場定義和範圍
  • 執行摘要

第3章：市場動態、監管與趨勢分析

  • 市場動態
  • 影響分析
  • 法規環境
  • 產品上市及核准
  • PEST分析
  • 波特的分析
  • 市場機遇
  • 法規環境
  • 產業趨勢

第4章 全球數位生物標記市場：按類型分類，2021-2033年

  • 診斷生物標記
  • 監測生物標記
  • 預測性和預後性生物標記

第5章 全球數位生物標記市場：依資料類型分類，2021-2033年

  • 生理數據
  • 行為數據
  • 生物化學/多模態數據

第6章 全球數位生物標記市場：依技術平台分類，2021-2033年

  • 穿戴式裝置
  • 行動應用
  • 感測器和遠端監控設備

第7章 全球數位生物標記市場：依最終用戶分類，2021-2033年

  • 製藥和生物技術公司
  • 醫療保健提供者
  • 研究機構
  • 其他

第8章 全球數位生物標記市場：按地區分類，2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲
  • 歐洲
    • 德國
    • 英國
    • 西班牙
    • 法國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • ASEAN
    • 其他亞太地區
  • 中東
    • GCC
    • 以色列
    • 其他中東國家
  • 非洲
    • 南非
    • 北非
    • 中非

第9章 競爭情勢

  • AliveCor Inc.
  • BioSensics
  • Evidation Health
  • Empatica Inc.
  • Koneksa Health
  • Huma Therapeutics
  • Altoida AG
  • IXICO plc
  • Oura Health
  • Verily Life Sciences

第10章 分析師建議

  • 機會
  • 連貫的機會地圖

第11章 參考文獻與調查方法

  • 參考
  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI5884

The global digital biomarker market is estimated to be valued at USD 4,850 Mn in 2026 and is expected to reach USD 16,900 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 19.5% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 4,850 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 19.50% 2033 Value Projection: USD 16,900 Mn

Digital biomarkers are considered to be a revolutionary development in modern healthcare since they provide an opportunity for quantitative analysis of biological data by means of various digital technologies like wearable devices, smartphones, and other types of sensors. As opposed to regular biomarkers, which require frequent visits to clinics and tests, digital biomarkers allow collecting information continuously and passively, thus allowing for a more accurate assessment of patients' health, progress of various diseases, and treatment outcomes. The evolution of digital biomarkers is contributing to the transformation of current healthcare towards data-driven and outcomes-oriented models.

The global digital biomarker industry includes various applications in therapeutic areas that include cardiovascular diseases, neurological disorders, respiratory disorders, mental health conditions, and others. Digital biomarkers can be generated from a variety of data sources, including physiological information, behavioral data, environmental indicators, and other types of information. Technological advancements in sensors, cloud computing, and data aggregation are contributing to the growth and adoption of digital biomarkers.

Market Dynamics

The global digital biomarker market has been driven by increased digitization of healthcare operations and value-driven healthcare delivery and research. More specifically, stakeholders in the healthcare field are looking for a way to gather frequent and objective data on patients to improve their decision-making capabilities and patient treatment outcomes. With the help of digital biomarkers, patients can collect data and use it as quantifiable digital endpoints that will be applied in clinical settings and pharmaceutical research. Additionally, cloud computing systems, as well as mHealth technology and improved data interoperability, increase the scalability and applicability of the aforementioned solutions.

However, the limitations of using digital biomarkers in healthcare include the inability to control the variability of data generated across different devices, insufficiently validated solutions, and difficulties connected to data governance. Nonetheless, multiple opportunities lie in the application of digital twin technology, multi-modal data analysis, and collaboration among different parties from various sectors including healthcare, pharmaceuticals, and technology. The expansion of the application range of digital biomarkers from research to population health management, risk identification, and treatment can further contribute to the growth of the market for digital biomarker.

Key Features of the Study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global digital biomarker market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include AliveCor Inc., BioSensics, Evidation Health, Empatica Inc., Koneksa Health, Huma Therapeutics, Altoida AG, IXICO plc, Oura Health, and Verily Life Sciences
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global digital biomarker market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global digital biomarker market

Market Segmentation

  • Type Insights (Revenue, USD Mn, 2021 - 2033)
    • Diagnostic Biomarkers
    • Monitoring Biomarkers
    • Predictive and Prognostic Biomarkers
  • Data Type Insights (Revenue, USD Mn, 2021 - 2033)
    • Physiological Data
    • Behavioral Data
    • Biochemical / Multi-modal Data
  • Technology Platform Insights (Revenue, USD Mn, 2021 - 2033)
    • Wearable Devices
    • Mobile Applications
    • Sensors and Remote Monitoring Devices
  • End User Insights (Revenue, USD Mn, 2021 - 2033)
    • Pharmaceutical and Biotechnology Companies
    • Healthcare Providers
    • Research Organizations
    • Others
  • Regional Insights (Revenue, USD Mn, 2021 - 2033)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • AliveCor Inc.
    • BioSensics
    • Evidation Health
    • Empatica Inc.
    • Koneksa Health
    • Huma Therapeutics
    • Altoida AG
    • IXICO plc
    • Oura Health
    • Verily Life Sciences

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Digital Biomarker Market, By Type
    • Global Digital Biomarker Market, By Data Type
    • Global Digital Biomarker Market, By Technology Platform
    • Global Digital Biomarker Market, By End User
    • Global Digital Biomarker Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Market Opportunities
  • Regulatory Scenario
  • Key Developments
  • Industry Trends

4. Global Digital Biomarker Market, By Type, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Diagnostic Biomarkers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Monitoring Biomarkers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Predictive and Prognostic Biomarkers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global Digital Biomarker Market, By Data Type, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Physiological Data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Behavioral Data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Biochemical / Multi-modal Data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global Digital Biomarker Market, By Technology Platform, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Wearable Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Mobile Applications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Sensors and Remote Monitoring Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

7. Global Digital Biomarker Market, By End User, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Pharmaceutical and Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Healthcare Providers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Research Organizations
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

8. Global Digital Biomarker Market, By Region, 2021 - 2033, Value (USD Mn)

  • Introduction
    • Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
    • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Data Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Data Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Data Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Data Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Data Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Data Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
      • South Africa
      • North Africa
      • Central Africa

9. Competitive Landscape

  • AliveCor Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • BioSensics
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Evidation Health
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Empatica Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Koneksa Health
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Huma Therapeutics
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Altoida AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • IXICO plc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Oura Health
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Verily Life Sciences
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us